Dr. Shangyun Zhou completed both his clinical psychology internship and postdoctoral fellowship at Massachusetts General Hospital/Harvard Medical School. He primarily provides CBT for OCD at CORD, while providing intergrative treatments at Primary Care Psychiatry.
Faculty
Cadence Trapini, M.D.*
Dr. Cadence Trapini completed her medical training at Stony Brook School of Medicine in New York before moving to Chicago for her general psychiatry residency at Rush University Medical Center. Additionally, Dr. Trapini completed the Jungian Psychotherapy Program at the C G Jung Institute of Chicago.
Natasha Bailen, Ph.D.*
Dr. Bailen received her PhD in clinical psychology from Washington University in St. Louis, and completed her clinical internship at University of Chicago Medicine. She completed her postdoctoral training at Boston University’s Center for Anxiety and Related Disorders (CARD). She is a licensed clinical psychologist in the state of Massachusetts and specializes in the cognitive-behavioral treatment of OCD, anxiety, and related disorders. Her research focuses on the role of dysregulated emotional processes in psychopathology.
Sarah Coe-Odess, Ph.D.*
Dr. Coe-Odess received her PhD in clinical psychology from the University of Virginia. She completed her clinical internship at Cambridge Health Alliance/HMS and her post-doctoral fellowship at MGH/HMS. She is a licensed clinical psychologist in the state of Massachusetts and specializes in cognitive-behavioral therapy for OCD and related disorders and anxiety disorders. Her research aims to assess and develop evidence-based treatments to increase accessibility of mental health care for adolescents and adults, particularly through digital interventions.
Geneva Jonathan, Ph.D.
Geneva Jonathan, PhD, is an Instructor at Harvard Medical School and a clinical psychologist at the Center for OCD and Related Disorders and the Center for Digital Mental Health at Massachusetts General Hospital. She received her BA from Wesleyan University and her PhD in clinical psychology from Northwestern University Feinberg School of Medicine, and completed her internship and postdoctoral fellowship at MGH/Harvard Medical School.
Dr. Jonathan’s research uses digital technology to expand access to cognitive-behavioral therapy for body dysmorphic disorder (BDD) and to detect risk, including substance use and suicide risk, in daily life. Her newest work examines how AI chatbots affect people with BDD. Her research is supported by a Harvard Medical School Zinberg Fellowship, and her honors include the 2025 ISRII Early Career Researcher Award and the 2025 ABCT Francis C. Sumner Excellence Award.







